Molecular modeling of human P450c17 (17α-hydroxylase/17,20-lyase):: Insights into reaction mechanisms and effects of mutations

被引:188
作者
Auchus, RJ
Miller, WL
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Internal Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA
关键词
D O I
10.1210/me.13.7.1169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P450c17 (17 alpha-hydroxylase/17,20-lyase) catalyzes steroid 17 alpha-hydroxylase and 17,20-lyase activities in the biosynthesis of androgens and estrogens. These two activities are differentially regulated in a tissue-specific and developmentally programmed manner. To visualize the active site topology of human P450c17 and to study the structural basis of its substrate specificity and catalytic selectivity, we constructed a second-generation computer-graphic model of human P450c17, The energetics of the model are comparable to those of the principal template of the model, P450BMP, as determined from its crystallographic coordinates. The protein structure analysis programs PROCHECK, WHATIF, and SurVol indicate that the predicted P450c17 structure is reasonable. The hydrophobic active site accommodates both Delta(4) and Delta(5) steroid substrates in a catalytically favorable orientation. The predicted contributions of positively charged residues to the redox-partner binding site were confirmed by site-directed mutagenesis. Molecular dynamic simulations with pregnenolone, 17-OH-pregnenolone, progesterone, and Il-OH-progesterone docked into the substrate-binding pocket demonstrated that regioselectivity of the hydroxylation reactions is determined both by proximity of hydrogens to the iron-ore complex and by the stability of the carbon radicals generated after hydrogen abstraction. The model explains the activities of all known naturally occurring and synthetic human P450c17 mutants. The model predicted that mutation of lysine 89 would disrupt 17,20-lyase activity to a greater extent than 17 alpha-hydroxylase activity; expression of a test mutant, K89N, in yeast confirmed this prediction. Hydrogen peroxide did not support catalysis of the 17,20-lyase reaction, as would be predicited by mechanisms involving a ferryl peroxide. Our present model and biochemical data suggest that both the hydroxylase and lyase activities proceed from a common steroid-binding geometry by an iron oxene mechanism. This model will facilitate studies of sex steroid synthesis and its disorders and the design of specific inhibitors useful in chemotherapy of sex steroid-dependent cancers.
引用
收藏
页码:1169 / 1182
页数:14
相关论文
共 72 条
[1]   COMPOUND HETEROZYGOUS MUTATIONS (ARG 239-]STOP, PRO 342-]THR) IN THE CYP17 (P45017-ALPHA) GENE LEAD TO AMBIGUOUS EXTERNAL GENITALIA IN A MALE-PATIENT WITH PARTIAL COMBINED 17-ALPHA-HYDROXYLASE 17,20-LYASE DEFICIENCY [J].
AHLGREN, R ;
YANASE, T ;
SIMPSON, ER ;
WINTER, JSD ;
WATERMAN, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03) :667-672
[2]   Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer [J].
Auchus, RJ ;
Lee, TC ;
Miller, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (06) :3158-3165
[3]   A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL [J].
BAYLY, CI ;
CIEPLAK, P ;
CORNELL, WD ;
KOLLMAN, PA .
JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) :10269-10280
[4]   A single amino acid substitution in the putative redox partner-binding site of P450c17 as cause of isolated 17,20-lyase deficiency [J].
BiasonLauber, A ;
Leiberman, E ;
Zachmann, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3807-3812
[5]   CRYSTALLIZATION AND PRELIMINARY-X-RAY DIFFRACTION ANALYSIS OF P450TERP AND THE HEMOPROTEIN DOMAIN OF P450BM-3, ENZYMES BELONGING TO 2 DISTINCT CLASSES OF THE CYTOCHROME P450 SUPERFAMILY [J].
BODDUPALLI, SS ;
HASEMANN, CA ;
RAVICHANDRAN, KG ;
LU, JY ;
GOLDSMITH, EJ ;
DEISENHOFER, J ;
PETERSON, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5567-5571
[6]  
Burke DF, 1997, ANTI-CANCER DRUG DES, V12, P113
[7]   Construction of a 3D model of cytochrome P450 2B4 [J].
Chang, YT ;
Stiffelman, OB ;
Vakser, IA ;
Loew, GH ;
Bridges, A ;
Waskell, L .
PROTEIN ENGINEERING, 1997, 10 (02) :119-129
[8]   CYTOCHROME P450C17 (STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE) - CLONING OF HUMAN ADRENAL AND TESTIS CDNAS INDICATES THE SAME GENE IS EXPRESSED IN BOTH TISSUES [J].
CHUNG, BC ;
PICADOLEONARD, J ;
HANIU, M ;
BIENKOWSKI, M ;
HALL, PF ;
SHIVELY, JE ;
MILLER, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :407-411
[9]   VALPROIC ACID METABOLISM BY CYTOCHROME-P450 - A THEORETICAL-STUDY OF STEREOELECTRONIC MODULATORS OF PRODUCT DISTRIBUTION [J].
COLLINS, JR ;
CAMPER, DL ;
LOEW, GH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (07) :2736-2743
[10]   A SYNDROME OF FEMALE PSEUDOHERMAPHRODISM, HYPERGONADOTROPIC HYPOGONADISM, AND MULTICYSTIC OVARIES ASSOCIATED WITH MISSENSE MUTATIONS IN THE GENE ENCODING AROMATASE (P450AROM) [J].
CONTE, FA ;
GRUMBACH, MM ;
ITO, Y ;
FISHER, CR ;
SIMPSON, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1287-1292